Log in or Sign up for Free to view tailored content for your specialty!
Vasculitis and Giant Cell Arteritis News
Rituximab successfully re-induces remission after ANCA-associated vasculitis relapse
Rituximab, used alongside glucocorticoids, is highly efficacious in re-inducing remission among relapsed patients with ANCA-associated vasculitis, according data published in Annals of the Rheumatic Diseases.
Establishing EGPA Diagnosis and Prognosis
Learning Objectives:
Log in or Sign up for Free to view tailored content for your specialty!
Behcet's disease remains largely unknown among physicians
The rare and complex Behcet’s disease is often misdiagnosed or undiagnosed, leading to significant, but unnecessary, morbidity, according to a presenter at the 2020 Interdisciplinary Autoimmune Summit.
COVID-19 infection rate in patients treated with DMARDs consistent with general population
The incidence and severity of COVID-19 among patients with rheumatic disease treated with targeted synthetic or biological DMARDs is consistent with those in the general population, according to data published in Arthritis & Rheumatology.
Serious infection-related hospitalization rates nearly doubled in vasculitis
The rate of hospitalizations due to serious infection in patients with vasculitis nearly doubled over a 19-year period, according to data published in Arthritis Care & Research.
Rituximab safe for long-term use in granulomatosis with polyangiitis, microscopic polyangiitis
The long-term safety of rituximab was consistent with a shorter duration of treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis, according to data published in Arthritis Care & Research.
Secukinumab safe, effective for Behçet's phenotype resistant to conventional treatment
Secukinumab was safe and effective for Behçet’s syndrome among patients with a mucosal and articular phenotype refractory to previous conventional and biologic treatments, according to data published in the Annals of the Rheumatic Diseases.
ACR unveils guidance for multisystem inflammatory syndrome in children with COVID-19
Multisystem inflammatory syndrome in children associated with COVID-19 may share overlapping clinical features with Kawasaki Disease unrelated to the pandemic, according to guidelines released by the American College of Rheumatology.
Patients with rheumatic disease, COVID-19 more likely to require ventilation
Patients with rheumatic diseases plus COVID-19 are more likely to require mechanical ventilation, but demonstrated similar clinical features and hospitalization rates as those with COVID-19 only, according to data published in the Annals of the Rheumatic Diseases.
Prolonged rituximab linked to lower ANCA-associated vasculitis relapse
A biannual regimen of rituximab infusions over the course of 18 months was associated with a lower incidence of relapse in ANCA-associated vasculitis, compared with standard maintenance therapy, according to data published in the Annals of Internal Medicine.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read